Leveraging innate immunity with AFM24, a novel CD16A and epidermal growth factor receptor (EGFR) bispecific innate cell engager: Interim results for the non-small cell lung cancer (NSCLC) cohort
El-Khoueiry et al.
ASCO 2023
El-Khoueiry et al.
ASCO 2023
Zambarda et al.
AACR 2023
Kim et al.
AACR 2023
Saavedra et al.
SITC 2022
Hintzen et al.
SITC 2022
Pinto et al.
Trends in Immunology 43(11): 932-46.
Hintzen et al.
Frontiers in Oncology. 2022 Sept 14
Anthony El-Khoueiry et al.
ESMO 2022
Sasse et al.,
Leuk Lymphoma. 2022; 63: 1871-1878.
Reusch et al.
Antibody Engin & Thera 2022